Katya KowalskiIs the Psychedelic Movement Elitist Toward Other Drugs?This piece was originally published for Volteface.Apr 16, 2021Apr 16, 2021
Katya KowalskiThe Moral Complexities of Drug PolicyThis piece was originally written for VoltefaceApr 12, 2021Apr 12, 2021
Katya KowalskiNew York Goes Legal, What Next?This piece was originally written for VoltefaceApr 12, 2021Apr 12, 2021
Katya KowalskiEnvironmental Benefits of HempThis piece was originally published for VoltefaceApr 12, 20211Apr 12, 20211
Katya KowalskiinEntheogenCurrent Psychedelic Research Lacks DiversityThis piece was originally published for VoltefaceFeb 16, 20212Feb 16, 20212
Katya KowalskiinInvisible IllnessWe Need To Talk About ComedownsThis piece was originally published for Volteface.Jan 8, 20211Jan 8, 20211
Katya KowalskiStop Calling it Recreational UseThis piece was originally published for Volteface.Dec 11, 2020Dec 11, 2020
Katya KowalskiinEntheogenCould Psychedelics Help Us Cope With COVID-19?Could mind-expanding drugs be a possible treatment?Dec 7, 2020Dec 7, 2020
Katya KowalskiinEntheogenInvestigating The Microdosing Experience: The Good, The Bad and The UnknownMicrodosing may improve productivity, creativity and mood, but what does the evidence say?Dec 5, 20202Dec 5, 20202
Katya KowalskiUN Vote: Cannabis is Officially a MedicineThis piece was originally written for Volteface.Dec 3, 2020Dec 3, 2020
